394 filings
Page 4 of 20
DEFA14A
mrqolql6gec4
17 Dec 21
Additional proxy soliciting materials
5:03pm
8-K
iz06cm2h6abrz0ia
17 Dec 21
Pulmatrix Announces Closing of $6.75 Million Registered Direct Offering
4:40pm
424B5
oc048
17 Dec 21
Prospectus supplement for primary offering
6:13am
DEFA14A
a9uel2
17 Dec 21
Additional proxy soliciting materials
6:09am
8-K/A
4tx6w7 kg6arqx0apng
17 Dec 21
Entry into a Material Definitive Agreement
6:08am
DEFA14A
c5qn25c
15 Dec 21
Additional proxy soliciting materials
5:27pm
8-K
r4xh0f
15 Dec 21
Pulmatrix Announces $6.75 Million Registered Direct Offering
5:27pm
8-K
0ripc5
7 Dec 21
Regulation FD Disclosure
9:25am
8-K
zmykd32mb9crbk7wc45
10 Nov 21
Pulmatrix Reports Third Quarter 2021 Financial Results and Provides Business Update
4:20pm
8-K
39zyb41fgswzpvw6jhz
9 Nov 21
Pulmatrix Announces Resolution of Contract Dispute with Cipla
9:15am
8-K
h8fswkg6depacj
23 Aug 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
f79jxhiq
10 Aug 21
Pulmatrix Reports Second Quarter 2021 Financial Results and Provides Business Update
9:15am
8-K
davhctlo syd
27 Jul 21
Departure of Directors or Certain Officers
12:26pm
D
uzlhxdm8vnxeptn
20 Jul 21
$19.63M in options / securities to be acquired, sold $45K, 5 investors
4:00pm
8-K
jr9b2zpaxswxuw3c
17 Jun 21
Submission of Matters to a Vote of Security Holders
5:28pm
8-K
sfoswk0m34i y1jjfnuh
16 Jun 21
Regulation FD Disclosure
5:15pm
EFFECT
ngk f4p0o
10 Jun 21
Notice of effectiveness
12:15am
UPLOAD
bt8l5
7 Jun 21
Letter from SEC
12:00am